Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis

J. van der Schaft; K. Politiek; J. M. P. A. van den Reek; W. Kievit; E. M. G. J. de Jong; C. A. F. M. Bruijnzeel-Koomen; M. L. A. Schuttelaar; M. S. de Bruin-Weller

doi:10.1111/bjd.14398

Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis

J. van der Schaft^*, K. Politiek, J. M. P. A. van den Reek, W. Kievit, E. M. G. J. de Jong, C. A. F. M. Bruijnzeel-Koomen, M. L. A. Schuttelaar, M. S. de Bruin-Weller

^*Corresponding author for this work

Public Health Research (PHR)

Research output: Contribution to journal › Letter › Academic › peer-review

27 Citations (Scopus)

1 Downloads (Pure)

Abstract

Results from clinical studies indicate that azathioprine and enteric-coated mycophenolate sodium (EC-MPS) are safe and potent drugs in the treatment of atopic dermatitis (AD).(1-5) However, published data from large groups of non-selected patients is non-existent to date which hampers generalization to daily practice. In addition, head-to-head trials in which azathioprine and EC-MPS are compared, have never been performed. The primary objective was to perform an analysis of drug survival for azathioprine and EC-MPS in a long-term daily practice cohort of patients with AD. The secondary objective was to identify determinants of drug survival. This article is protected by copyright. All rights reserved.

Original language	English
Pages (from-to)	199-202
Number of pages	4
Journal	The British journal of dermatology
Volume	175
Issue number	1
DOIs	https://doi.org/10.1111/bjd.14398
Publication status	Published - Jul-2016

Keywords

RANDOMIZED CONTROLLED-TRIAL

Access to Document

10.1111/bjd.14398

Drug survival for azathioprine and enteric‐coatedFinal publisher's version, 273 KBLicence: Taverne

Handle.net

Persistent link

Cite this

van der Schaft, J., Politiek, K., van den Reek, J. M. P. A., Kievit, W., de Jong, E. M. G. J., Bruijnzeel-Koomen, C. A. F. M., Schuttelaar, M. L. A., & de Bruin-Weller, M. S. (2016). Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis. The British journal of dermatology, 175(1), 199-202. https://doi.org/10.1111/bjd.14398

@article{fe68fd57005b41739717da74b5fa0287,

title = "Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis",

abstract = "Results from clinical studies indicate that azathioprine and enteric-coated mycophenolate sodium (EC-MPS) are safe and potent drugs in the treatment of atopic dermatitis (AD).(1-5) However, published data from large groups of non-selected patients is non-existent to date which hampers generalization to daily practice. In addition, head-to-head trials in which azathioprine and EC-MPS are compared, have never been performed. The primary objective was to perform an analysis of drug survival for azathioprine and EC-MPS in a long-term daily practice cohort of patients with AD. The secondary objective was to identify determinants of drug survival. This article is protected by copyright. All rights reserved.",

keywords = "RANDOMIZED CONTROLLED-TRIAL",

author = "{van der Schaft}, J. and K. Politiek and {van den Reek}, {J. M. P. A.} and W. Kievit and {de Jong}, {E. M. G. J.} and Bruijnzeel-Koomen, {C. A. F. M.} and Schuttelaar, {M. L. A.} and {de Bruin-Weller}, {M. S.}",

year = "2016",

month = jul,

doi = "10.1111/bjd.14398",

language = "English",

volume = "175",

pages = "199--202",

journal = "The British journal of dermatology",

issn = "0007-0963",

publisher = "Wiley",

number = "1",

}

van der Schaft, J, Politiek, K, van den Reek, JMPA, Kievit, W, de Jong, EMGJ, Bruijnzeel-Koomen, CAFM, Schuttelaar, MLA & de Bruin-Weller, MS 2016, 'Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis', The British journal of dermatology, vol. 175, no. 1, pp. 199-202. https://doi.org/10.1111/bjd.14398

Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis. / van der Schaft, J.; Politiek, K.; van den Reek, J. M. P. A. et al.
In: The British journal of dermatology, Vol. 175, No. 1, 07.2016, p. 199-202.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis

AU - van der Schaft, J.

AU - Politiek, K.

AU - van den Reek, J. M. P. A.

AU - Kievit, W.

AU - de Jong, E. M. G. J.

AU - Bruijnzeel-Koomen, C. A. F. M.

AU - Schuttelaar, M. L. A.

AU - de Bruin-Weller, M. S.

PY - 2016/7

Y1 - 2016/7

N2 - Results from clinical studies indicate that azathioprine and enteric-coated mycophenolate sodium (EC-MPS) are safe and potent drugs in the treatment of atopic dermatitis (AD).(1-5) However, published data from large groups of non-selected patients is non-existent to date which hampers generalization to daily practice. In addition, head-to-head trials in which azathioprine and EC-MPS are compared, have never been performed. The primary objective was to perform an analysis of drug survival for azathioprine and EC-MPS in a long-term daily practice cohort of patients with AD. The secondary objective was to identify determinants of drug survival. This article is protected by copyright. All rights reserved.

AB - Results from clinical studies indicate that azathioprine and enteric-coated mycophenolate sodium (EC-MPS) are safe and potent drugs in the treatment of atopic dermatitis (AD).(1-5) However, published data from large groups of non-selected patients is non-existent to date which hampers generalization to daily practice. In addition, head-to-head trials in which azathioprine and EC-MPS are compared, have never been performed. The primary objective was to perform an analysis of drug survival for azathioprine and EC-MPS in a long-term daily practice cohort of patients with AD. The secondary objective was to identify determinants of drug survival. This article is protected by copyright. All rights reserved.

KW - RANDOMIZED CONTROLLED-TRIAL

U2 - 10.1111/bjd.14398

DO - 10.1111/bjd.14398

M3 - Letter

C2 - 26785104

SN - 0007-0963

VL - 175

SP - 199

EP - 202

JO - The British journal of dermatology

JF - The British journal of dermatology

IS - 1

ER -

Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this